TipHub

₹3.2

■ +0 +0.00%

29 Jul 2026

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

Zenith Health Care Ltd. (530665)

Volume: 14,487Avg Vol 1W: 17,913Avg Vol 1M: 34,19252W Range:₹2.23₹4.99
BSE www.zenithhealthcare.com AI Report
Key Ratios
Checked 2h ago
Market Cap₹17 Cr
Current Price₹3.2
Previous Close₹3.2
High / Low (52w)₹4.99 / ₹2.23
Volume14,487
Avg Vol (1W)17,913
Avg Vol (1M)34,192
Stock P/E—
Book Value₹1.38
Dividend Yield0%
ROE7%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding5 Cr
Face Value—
EPS (TTM)₹0
P/B2.32
Debt / Equity0
50 DMA₹3.19
200 DMA₹3.39
Day change+0.00%
SurveillanceGSM · GSM 0
Price Chart
₹3.2▼ 21.95% · 1Y
₹5₹22.9L
2025-07-29
2026-07-29

20-day avg volume: 34K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 20% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹10 Cr₹10 Cr₹12 Cr₹14 Cr₹23 Cr₹14 Cr₹15 Cr₹12 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0.050.030.110.080.060.010.040.01
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹7 Cr₹7 Cr₹9 Cr₹9 Cr₹12 Cr₹9 Cr₹10 Cr₹11 Cr
Total Liabilities₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹5 Cr₹2 Cr₹3 Cr₹3 Cr
Equity₹6 Cr₹6 Cr₹6 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹2 Cr₹-1 Cr₹2 Cr₹1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹-2 Cr₹-1 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹-1 Cr₹2 Cr₹-1 Cr₹2 Cr₹1 Cr
Shareholding
Promoter 28.74% Institutions 0.39% Public 70.87%
Efficiency & Working Capital
ROCE0.3%
Interest Coverage23
Dividend Payout—
Debtor Days78 d
Inventory Days73 d
Payable Days44 d
Cash Conversion Cycle107 d
Working Capital Days151 d
Shareholding Details

As of 2026-06-30

Promoter28.7%
FII0%
DII0.4%
Institutions0.4%
Public70.9%
Promoter Pledge0%
No. of Shareholders38,725
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters28.7%28.7%28.7%28.7%28.7%28.7%28.7%28.7%28.7%28.7%28.7%28.7%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%
Public70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders33,14733,32633,87933,88636,49139,95941,28441,13740,45439,69339,07738,725
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Mahendra Chatrabhuj RaychaShareholding of Promoter and Promoter Group12.3%66,04,000
Mahendra Chatrabhujbhai Raycha HufShareholding of Promoter and Promoter Group9.6%51,29,500
Zenith Life Care Private LimitedShareholding of Promoter and Promoter Group3.7%19,96,550
Sharpline Trading Co. Pvt. Ltd.Public Shareholding3.3%17,66,450
Neela Mahendra RaychaShareholding of Promoter and Promoter Group2.4%12,61,712
Harsh JhaveriPublic Shareholding2.2%11,78,000
Ray Remedies Pvt. Ltd.Shareholding of Promoter and Promoter Group0.5%2,56,000
Raycha Akshit MahendraShareholding of Promoter and Promoter Group0.4%1,89,817
Ashwin M. ThakkerShareholding of Promoter and Promoter Group0%4,500
Divyesh ShahShareholding of Promoter and Promoter Group0%500
Atul CholeraShareholding of Promoter and Promoter Group0%500
Ashwin CholeraShareholding of Promoter and Promoter Group0%500
Board of Directors
NameDesignationYear
Mahendra C RaychaChairman / Executive Director / M D / Promoter2025
Akshit RaychaED / Joint MD / Promoter2025
Neela RaychaNon-Exec & Non-Independent Dir2025
Atul ThakkerNon-Exec & Non-Independent Dir2025
Parag DaveIndependent Non Exe. Director2025
Rutvik Sanjaykumar ThakkarIndependent Non Exe. Director2025
RAJESH CHINUBHAI SUTARIAIndependent Non Exe. Director2025
Mihir Satishkumar ShahCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹11155
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000001
2025000000
2025000000
Company Information
Incorporated1994
ChairmanMahendra C Raycha
AuditorDoshi Doshi & Co
Investor Email[email protected]
🌐 www.zenithhealthcare.com ↗

📍 504 Iscon Elegance S G Road, Nr Ananddham Jain Derasar, Ahmedabad, Gujarat, 380051

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Garg Furnace Ltd.Sampre Nutritions Ltd.Akar Auto Industries LimitedVipul Organics LimitedEco Recycling Ltd.Goyal Associates Ltd.Ace Engitech LimitedYork Exports Ltd.Supreme Holdings & HospitalityPithampur Poly Products LimitedLykis LimitedPrime Property Development Corporation Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search